Cadila Healthcare Q4 PAT seen up 36.5% YoY to Rs. 530 cr: HDFC Securities

HDFC Securities has come out with its fourth quarter (Jan-March’ 18) earnings estimates for the Pharmaceuticals sector. The brokerage house expects Cadila Healthcare to report net profit at Rs. 530 crore up 36.5% year-on-year (down 3.1% quarter-on-quarter).

Net Sales are expected to increase by 24 percent Y-o-Y (down 5.7 percent Q-o-Q) to Rs. 3,070 crore, according to HDFC Securities.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 48.3 percent Y-o-Y (down 13.6 percent Q-o-Q) to Rs. 730 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions